menu search

Anglo asian production disrupted by tailings review

Anglo Asian Mining has reiterated its revised production guidance and does not expect any production from its flotation and ...

October 16, 2023, 2:47 am

Why shares of bioxcel therapeutics fell this week

The company has one marketed treatment -- Igalmi, which reduces agitation in patients with bipolar diso...

September 28, 2023, 5:35 pm

Anglo asian assuming no flotation plant restart this year

Anglo Asian Mining flotation and agitation plant at its Gedabek mine in Azerbaijan won't be back up and...

September 26, 2023, 3:18 am

Global acute agitation and aggression treatment market is anticipated to reach us$ 7.09 billion by 2031, progressing at a 5.1% cagr: tmr report  

Rise in burden of mental illnesses and increase in agitation in patients are projected to boost the gro...

September 25, 2023, 2:34 pm

Chhattisgarh health federation continues agitation as govt dismisses 205 employees amidst ongoing protest

Raipur: The health workers under Chhattisgarh Health Federation are continuing with their agitation for...

September 3, 2023, 7:29 pm

Bioxcel therapeutics announces positive topline results from tranquility ii phase 3 trial of bxcl501 for acute treatment of alzheimer’s disease-related agitation

Trial met primary endpoint with the 60 mcg dose, with BXCL501 demonstrating a statistically significant 39% greater reduction in PEC score from baseli...

June 29, 2023, 10:00 am

Why is bioxcel therapeutics (btai) stock down 57% today?

BioXcel Therapeutics (NASDAQ: BTAI ) stock is taking a beating on Thursday after the company released its latest clinical trial data. BioXcel Therape...

June 29, 2023, 8:57 am

Bioxcel therapeutics's drug meets key trial goal to treat alzheimer's patients

BioXcel Therapeutics said on Thursday its experimental drug to treat agitation related to Alzheimer's d...

June 29, 2023, 6:20 am

Why shares of bioxcel therapeutics are dropping thursday

BioXcel Therapeutics got approval last year for Igalmi to treat acute agitation in adults with schizoph...

May 25, 2023, 12:40 pm

Bioxcel stock crashes 22% as bid to double its market appears less certain

Shares of BTAI stock plummeted after BioXcel's Igalmi missed the mark in patients with agitation due to...

May 25, 2023, 12:04 pm

Is a victory for its rivals bad news for axsome therapeutics?

The partnership of Otsuka Pharmaceutical and Lundbeck beat Axsome to market with the first approved treatment for Alzheimer's disease ...

May 17, 2023, 5:30 am

Axsome: more catalysts stacking for 2023

In its early launch for depression, Axsome Therapeutics, Inc.'s Auvelity is already garnering robust market adoption. Demonstrating its therapeutic pr...

December 8, 2022, 12:05 pm

Biopharma co. trades to new 52-week high

Source: Streetwise Reports (11/28/22) Shares of Axsome Therapeutics Inc. traded to a new 52-week high after the company reported its AXS-05 successful...

November 29, 2022, 9:23 pm

Axsome (axsm) gains as alzheimer's agitation study meets goal

Axsome's (AXSM) phase III ACCORD study evaluating AXS-05 for treating Alzheimer's disease agitation met...

November 29, 2022, 2:18 pm

Axsome therapeutics announces axs-05 achieves primary endpoint in the accord phase 3 trial in alzheimer’s disease agitation

AXS-05 statistically significantly delayed time to relapse of Alzheimer’s disease agitation versus pl...

November 28, 2022, 11:35 am

Axsome's stock rallies 15% on promising findings for its experimental alzheimer's drug

Shares of Axsome Therapeutics Inc. AXSM, +1.07% jumped 15.5% in premarket trading on Monday after the company said its Alzheimer's treatment candidate...

November 28, 2022, 8:36 am

Bioxcel therapeutics: bxcl501 for acute agitation in patients with dementia and alzheimer's - a great asset

BioXcel is currently conducting phase II and III trials of BXCL501 to treat acute agitation in patients...

July 19, 2022, 5:02 am

Why bioxcel therapeutics stock is surging today

BioXcel Therapeutics Inc (NASDAQ: BTAI) shares are trading higher Wednesday after the company announced that the U.S. Food and Drug Administration app...

April 6, 2022, 9:22 am

Bioxcel says the fda approved its therapy for adults with schizophrenia or bipolar disorder

Shares of BioXcel Therapeutics Inc. BTAI, -2.98% jumped 14.6% in premarket trading on Wednesday after the company said the Food and Drug Administratio...

April 6, 2022, 8:02 am

7 safe defensive stocks to buy as market agitation rises

Remove the worry associated with volatile, unpredictable stock markets by buying these dividend-paying safe stocks. The post 7 Safe Defensive Stocks t...

February 28, 2022, 6:00 am


Search within

Pages Search Results: